Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit

—Movers in Rare Disease Summit Will Include Elevator Pitches from Rare Disease Companies
with “Key, Near-Term, Potentially Stock-Moving Catalysts”—

TEL AVIV, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that it will participate in Oppenheimer's Movers in Rare Disease Summit on Thursday, December 12, 2024, at the Westin Grand Central in New York City. The invitation-only Rare Disease Summit will feature a day of panels, presentations and 1-on-1 investor meetings with companies working in the rare disease space.

Read more at globenewswire.com